Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Health
By BY CHRISTINA JEWETT AND PAM BELLUCK from NYT Health https://ift.tt/Db0v7o3
via IFTTT Drugs (Pharmaceuticals), Decisions and Verdicts, Abortion, Regulation and Deregulation of Industry, Abortion Drugs, Federal-State Relations (US), Suits and Litigation (Civil) Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda